Comparative Study of Nasal Packing Duration: One-Day Packing Versus Three-Day Packing After Turbinate Surgery

August 15, 2026 updated by: Amin Khaled Amin ELBatawy, Tanta University
This study aimed to assess the optimum timing for nasal packs removal after turbinate surgery by comparing removal after one day versus removal after three days.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Nasal obstruction is a common symptom that reaches 25% of the population worldwide. The main etiologies for nasal obstruction are septal deviation, hypertrophy of the inferior and middle turbinates, and nasal polyposis.

Hypertrophied inferior turbinate surgery techniques include Cauterization, Radiofrequency turbinate reduction, Coblation, Submucosal diathermy, Microdebrider and submucosal resection.

Endoscopic Partial inferior turbinectomy addresses both the hypertrophic mucosa and the underlying bone while leaving a normal-sized turbinate behind.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Al Gharbia
      • Tanta, Al Gharbia, Egypt, 31739
        • Tanta University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged from 18 years to 45 years old.
  • Both sexes.
  • Patients with inferior turbinate hypertrophy.
  • Following unsatisfactory medical treatment for at least three months.

Exclusion Criteria:

  • Medically unfit patients (hypertensive and diabetic patients).
  • Patients with bleeding tendencies.
  • patients with Severe deviated septum.
  • Congenital anomalies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group (A)
Patients were scheduled for nasal packing for 1 day
Procedure: Nasal packing for 1 day
Patients were scheduled for nasal packing for 1 day
Experimental: Group (B)
Patients were scheduled for nasal packing for 3 days
Procedure: Nasal packing for 3 days
Patients were scheduled for nasal packing for 3 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative bleeding
Time Frame: Six months after surgery
Incidence of postoperative bleeding was recorded.
Six months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement in nasal obstruction
Time Frame: Six months after surgery
Improvement in nasal obstruction was assessed using the legalized Arabic version of the Nasal Obstruction Symptom Evaluation (Arabic NOSE) scale. The Arabic NOSE scale consists of five items scored on a five-point Likert scale, with total scores extending from 0 to 100; developed scores indicate more severe nasal obstruction.
Six months after surgery
Bleeding during nasal pack removal
Time Frame: Intraoperatively
Incidence of bleeding during nasal pack removal was recorded.
Intraoperatively
Postoperative pain
Time Frame: Six months after surgery
Postoperative pain was judged utilizing the Visual Analogue Scale (VAS). VAS is a straight 10-centimeter line where 0 means no pain and 10 means the worst pain.
Six months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tanta University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Actual)

January 1, 2026

Study Completion (Actual)

January 1, 2026

Study Registration Dates

First Submitted

August 15, 2026

First Submitted That Met QC Criteria

August 15, 2026

First Posted (Actual)

August 20, 2026

Study Record Updates

Last Update Posted (Actual)

August 20, 2026

Last Update Submitted That Met QC Criteria

August 15, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 36264MS764/12/24

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

IPD Sharing Time Frame

After the end of study for one year.

IPD Sharing Access Criteria

The data will be available upon a reasonable request from the corresponding autho

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe